University of Michigan
The proposed study aims to establish the feasibility of light therapy for postpartum depression delivered via Re-Timer, demonstrate its preliminary efficacy, and illuminate relationships between circadian shifts and mood changes using a novel, home-based circadian biomarker assessment paradigm (salivary dim light melatonin onset; DLMO).
- Device: Light therapyLight therapy glasses
|Ages eligible for Study||18 Years and older|
|Genders eligible for Study||Female|
|Accepts Healthy Volunteers||No|
- Within 6 months postpartum
- Meet DSM-V diagnostic criteria for MDD
- Score ≥ 20 on the Structured Interview Guide for the Hamilton Depression Rating Scale-Seasonal Affective Disorder version (SIGH-SAD).
- current diagnosis of bipolar disorder, posttraumatic stress disorder, schizophrenia or psychosis, dissociative disorders, eating disorder, obsessive-compulsive disorder, somatic symptom and related disorders, substance use disorder, panic disorder, agoraphobia per DSM-V
- past history of mania/hypomania,
- chronic medical conditions associated with depression (e.g., thyroid conditions)
- ocular or retinal pathology
- history of seizures or epilepsy
- color blindness
- currently taking an antibiotic, medication that contains hydrochlorothiazide, or isotretinoin (Accutane).
United States (1)
- University of MichiganNot specifiedAnn Arbor, Michigan, United States, 48109
Participant Flow: Overall Study
Serious Adverse Events
Other Adverse Events
31 May, 2015
19 December, 2017